Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Indole Inhibits ToxR Regulon Expression in Vibrio cholerae.

Howard MF, Bina XR, Bina JE.

Infect Immun. 2019 Feb 21;87(3). pii: e00776-18. doi: 10.1128/IAI.00776-18. Print 2019 Mar.

2.

The Vibrio cholerae RND efflux systems impact virulence factor production and adaptive responses via periplasmic sensor proteins.

Bina XR, Howard MF, Taylor-Mulneix DL, Ante VM, Kunkle DE, Bina JE.

PLoS Pathog. 2018 Jan 5;14(1):e1006804. doi: 10.1371/journal.ppat.1006804. eCollection 2018 Jan.

3.

The Vibrio cholerae VexGH RND Efflux System Maintains Cellular Homeostasis by Effluxing Vibriobactin.

Kunkle DE, Bina XR, Bina JE.

MBio. 2017 May 16;8(3). pii: e00126-17. doi: 10.1128/mBio.00126-17.

4.

Vibrio cholerae LeuO Links the ToxR Regulon to Expression of Lipid A Remodeling Genes.

Bina XR, Howard MF, Ante VM, Bina JE.

Infect Immun. 2016 Oct 17;84(11):3161-3171. doi: 10.1128/IAI.00445-16. Print 2016 Nov.

5.

The LysR-type regulator LeuO regulates the acid tolerance response in Vibrio cholerae.

Ante VM, Bina XR, Bina JE.

Microbiology. 2015 Dec;161(12):2434-43. doi: 10.1099/mic.0.000194. Epub 2015 Sep 29.

6.

Vibrio cholerae leuO Transcription Is Positively Regulated by ToxR and Contributes to Bile Resistance.

Ante VM, Bina XR, Howard MF, Sayeed S, Taylor DL, Bina JE.

J Bacteriol. 2015 Nov;197(22):3499-510. doi: 10.1128/JB.00419-15. Epub 2015 Aug 24.

7.

Substrate-dependent activation of the Vibrio cholerae vexAB RND efflux system requires vexR.

Taylor DL, Ante VM, Bina XR, Howard MF, Bina JE.

PLoS One. 2015 Feb 19;10(2):e0117890. doi: 10.1371/journal.pone.0117890. eCollection 2015.

8.

Construction of a tetracycline inducible expression vector and characterization of its use in Vibrio cholerae.

Bina XR, Wong EA, Bina TF, Bina JE.

Plasmid. 2014 Nov;76:87-94. doi: 10.1016/j.plasmid.2014.10.004. Epub 2014 Oct 24.

9.

Reciprocal regulation of resistance-nodulation-division efflux systems and the Cpx two-component system in Vibrio cholerae.

Taylor DL, Bina XR, Slamti L, Waldor MK, Bina JE.

Infect Immun. 2014 Jul;82(7):2980-91. doi: 10.1128/IAI.00025-14. Epub 2014 May 5.

10.

Cyclo(valine-valine) inhibits Vibrio cholerae virulence gene expression.

Vikram A, Ante VM, Bina XR, Zhu Q, Liu X, Bina JE.

Microbiology. 2014 Jun;160(Pt 6):1054-62. doi: 10.1099/mic.0.077297-0. Epub 2014 Mar 18.

11.

Decisional involvement: actual and preferred involvement in decision-making among registered nurses.

Bina JS, Schomburg MK, Tippetts LA, Scherb CA, Specht JK, Schwichtenberg T.

West J Nurs Res. 2014 Apr;36(4):440-55. doi: 10.1177/0193945913503717. Epub 2013 Sep 5.

PMID:
24014616
12.

Vibrio cholerae ToxR downregulates virulence factor production in response to cyclo(Phe-Pro).

Bina XR, Taylor DL, Vikram A, Ante VM, Bina JE.

MBio. 2013 Aug 27;4(5):e00366-13. doi: 10.1128/mBio.00366-13.

13.

Riboswitches for intracellular study of genes involved in Francisella pathogenesis.

Reynoso CM, Miller MA, Bina JE, Gallivan JP, Weiss DS.

MBio. 2012 Nov 20;3(6). pii: e00253-12. doi: 10.1128/mBio.00253-12.

14.

Link between intraphagosomal biotin and rapid phagosomal escape in Francisella.

Napier BA, Meyer L, Bina JE, Miller MA, Sjöstedt A, Weiss DS.

Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18084-9. doi: 10.1073/pnas.1206411109. Epub 2012 Oct 15.

15.

NaxD is a deacetylase required for lipid A modification and Francisella pathogenesis.

Llewellyn AC, Zhao J, Song F, Parvathareddy J, Xu Q, Napier BA, Laroui H, Merlin D, Bina JE, Cotter PA, Miller MA, Raetz CR, Weiss DS.

Mol Microbiol. 2012 Nov;86(3):611-27. doi: 10.1111/mmi.12004. Epub 2012 Sep 11.

16.

Vibrio cholerae VexH encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilus.

Taylor DL, Bina XR, Bina JE.

PLoS One. 2012;7(5):e38208. doi: 10.1371/journal.pone.0038208. Epub 2012 May 30.

17.

Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia.

Miller MA, Stabenow JM, Parvathareddy J, Wodowski AJ, Fabrizio TP, Bina XR, Zalduondo L, Bina JE.

PLoS One. 2012;7(2):e31359. doi: 10.1371/journal.pone.0031359. Epub 2012 Feb 24.

18.

Macrophage replication screen identifies a novel Francisella hydroperoxide resistance protein involved in virulence.

Llewellyn AC, Jones CL, Napier BA, Bina JE, Weiss DS.

PLoS One. 2011;6(9):e24201. doi: 10.1371/journal.pone.0024201. Epub 2011 Sep 6.

19.

A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia.

Jayakar HR, Parvathareddy J, Fitzpatrick EA, Bina XR, Bina JE, Re F, Emery FD, Miller MA.

BMC Microbiol. 2011 Aug 5;11:179. doi: 10.1186/1471-2180-11-179.

20.

Construction of a bioluminescence reporter plasmid for Francisella tularensis.

Bina XR, Miller MA, Bina JE.

Plasmid. 2010 Nov;64(3):156-61. doi: 10.1016/j.plasmid.2010.07.001. Epub 2010 Jul 8.

21.

The cyclic dipeptide cyclo(Phe-Pro) inhibits cholera toxin and toxin-coregulated pilus production in O1 El Tor Vibrio cholerae.

Bina XR, Bina JE.

J Bacteriol. 2010 Jul;192(14):3829-32. doi: 10.1128/JB.00191-10. Epub 2010 May 7.

22.

Binding and activation of host plasminogen on the surface of Francisella tularensis.

Clinton SR, Bina JE, Hatch TP, Whitt MA, Miller MA.

BMC Microbiol. 2010 Mar 12;10:76. doi: 10.1186/1471-2180-10-76.

23.

Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae.

Bina XR, Philippart JA, Bina JE.

J Antimicrob Chemother. 2009 Jan;63(1):103-8. doi: 10.1093/jac/dkn466. Epub 2008 Nov 14.

PMID:
19010827
24.

Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine.

Bina XR, Provenzano D, Nguyen N, Bina JE.

Infect Immun. 2008 Aug;76(8):3595-605. doi: 10.1128/IAI.01620-07. Epub 2008 May 19.

25.

The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice.

Bina XR, Lavine CL, Miller MA, Bina JE.

FEMS Microbiol Lett. 2008 Feb;279(2):226-33. doi: 10.1111/j.1574-6968.2007.01033.x. Epub 2007 Dec 20.

26.

Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR) 2/TLR1 heterodimer.

Thakran S, Li H, Lavine CL, Miller MA, Bina JE, Bina XR, Re F.

J Biol Chem. 2008 Feb 15;283(7):3751-60. Epub 2007 Dec 13.

27.

Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity.

Lavine CL, Clinton SR, Angelova-Fischer I, Marion TN, Bina XR, Bina JE, Whitt MA, Miller MA.

Eur J Immunol. 2007 Nov;37(11):3007-20.

28.

Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation.

Li H, Nookala S, Bina XR, Bina JE, Re F.

J Leukoc Biol. 2006 Oct;80(4):766-73. Epub 2006 Aug 8.

PMID:
16895974
29.
30.

Characterization of the Vibrio cholerae vexAB and vexCD efflux systems.

Bina JE, Provenzano D, Wang C, Bina XR, Mekalanos JJ.

Arch Microbiol. 2006 Sep;186(3):171-81. Epub 2006 Jun 28.

PMID:
16804679
31.

[Clinical-epidemiological characteristics of a group of HIV/AIDS infected women in Salvador-Bahia].

Nunes Cde L, Gonçalves LA, Silva PT, Bina JC.

Rev Soc Bras Med Trop. 2004 Nov-Dec;37(6):436-40. Portuguese.

PMID:
15765590
32.

Penicillin at the late stage of leptospirosis: a randomized controlled trial.

Costa E, Lopes AA, Sacramento E, Costa YA, Matos ED, Lopes MB, Bina JC.

Rev Inst Med Trop Sao Paulo. 2003 May-Jun;45(3):141-5. Epub 2003 Jul 8.

33.

[Leptospiral infection and subclinical presentation among children in Salvador, Bahia].

Silva HR, Tavares-Neto J, Bina JC, Meyer R.

Rev Soc Bras Med Trop. 2003 Mar-Apr;36(2):227-33. Epub 2003 Jun 10. Portuguese.

34.

[Schistosomiasis in hyperendemic area of Taquarendi: I- Schistosoma mansoni infection and severe clinical forms].

Bina JC, Prata A.

Rev Soc Bras Med Trop. 2003 Mar-Apr;36(2):211-6. Epub 2003 Jun 10. Portuguese.

35.

ToxR regulon of Vibrio cholerae and its expression in vibrios shed by cholera patients.

Bina J, Zhu J, Dziejman M, Faruque S, Calderwood S, Mekalanos J.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2801-6. Epub 2003 Feb 24.

36.

Soft tissue thermodynamics before, during, and after cold pack therapy.

Enwemeka CS, Allen C, Avila P, Bina J, Konrade J, Munns S.

Med Sci Sports Exerc. 2002 Jan;34(1):45-50.

PMID:
11782646
37.

The association between serum potassium at hospital admission and the case-fatality rate of leptospirosis in men.

Lopes AA, Costa E, Costa YA, Bina JC, Sacramento E.

Rev Inst Med Trop Sao Paulo. 2001 Jul-Aug;43(4):217-20.

38.

[Severe forms of leptospirosis: clinical, demographic and environmental aspects].

Costa E, Costa YA, Lopes AA, Sacramento E, Bina JC.

Rev Soc Bras Med Trop. 2001 May-Jun;34(3):261-7. Portuguese.

39.

Vibrio cholerae tolC is required for bile resistance and colonization.

Bina JE, Mekalanos JJ.

Infect Immun. 2001 Jul;69(7):4681-5.

40.

Facial nerve palsy associated with leptospirosis.

Costa E, Sacramento E, Lopes AA, Bina JC.

Rev Soc Bras Med Trop. 2001 Mar-Apr;34(2):219-20.

41.

Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families.

Alm RA, Bina J, Andrews BM, Doig P, Hancock RE, Trust TJ.

Infect Immun. 2000 Jul;68(7):4155-68.

43.

Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro.

Bina JE, Alm RA, Uria-Nickelsen M, Thomas SR, Trust TJ, Hancock RE.

Antimicrob Agents Chemother. 2000 Feb;44(2):248-54.

44.

[High intensity signal in basal ganglia on T1 weighted images: case report in Manson's Schistosomiasis with portal systemic encephalopathy].

Machado Júnior MA, Gaspar Sobrinho FP, Barbosa VA, Bina JC, Matos Hde S.

Arq Neuropsiquiatr. 1999 Jun;57(2A):306-10. Review. Portuguese.

PMID:
10412536
45.

Helicobacter pylori: a surprisingly conserved bacterium.

Hancock RE, Alm R, Bina J, Trust T.

Nat Biotechnol. 1998 Mar;16(3):216-7. No abstract available.

PMID:
9527991
47.

Characteristics of the acquired immunodeficiency syndrome in Brazil.

Moreira Júnior ED, Silva N, Brites C, Carvalho EM, Bina JC, Badaro R, Johnson WD Jr.

Am J Trop Med Hyg. 1993 May;48(5):687-92.

PMID:
8517487
48.

Correlation between cell-mediated immunity and degree of infection in subjects living in an endemic area of schistosomiasis.

de Jesus AM, Almeida RP, Bacellar O, Araujo MI, Demeure C, Bina JC, Dessein AJ, Carvalho EM.

Eur J Immunol. 1993 Jan;23(1):152-8.

PMID:
8419165
49.

[Specific treatment as a weapon for controlling schistosomiasis].

Bina JC.

Mem Inst Oswaldo Cruz. 1992;87 Suppl 4:195-202. Review. Portuguese.

50.

Multiple drug regimen for severe diarrhea associated with Cryptosporidium in AIDS patients.

Brites CB, Moreira Júnior ED, Bina JC, Johnson Júnior WD, Badaró R.

Rev Soc Bras Med Trop. 1991 Apr-Jun;24(2):117. No abstract available.

PMID:
1841427

Supplemental Content

Support Center